Purdue Pharma pleads guilty to criminal charges, admits role in opioid epidemic

Purdue Pharma headquarters.
(Image credit: Drew Angerer/Getty Images)

Purdue Pharma, which produces on OxyContin, on Tuesday admitted its role in the growth of the United States' opioid epidemic, pleading guilty to a set of criminal charges as part of a settlement with the federal government, The Associated Press reports.

The guilty plea included admissions that the pharmaceutical giant impeded the Drug Enforcement Administration's efforts to combat the opioid crisis. The company admitted it failed to maintain an effective program (despite assuring the DEA otherwise) focused on preventing prescription drugs from making it onto the black market. It provided the agency with misleading information so it could boost manufacturing quotas, and paid doctors through a speakers program as incentive for them to write more painkiller prescriptions.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
Explore More
Tim O'Donnell

Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.